References
- AshersonKuntsiUnravelling the complexity of attention-deficit hyperactivity disorder: a behavioural genomic approachBr J Psychiatry200518710310516055819
- FordTGoodmanRMeltzerHThe British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disordersJ Am Acad Child Adolesc Psychiatry200342101203121114560170
- RussellGRodgersLRUkoumunneOCFordTPrevalence of parent-reported ASD and ADHD in the UK: findings from the Millennium Cohort StudyJ Autism Dev Disord2014441314023719853
- HansenKJoshiHChildren of the 21st century: The first five yearsLondonThe Policy Press2010
- PolanczykGde LimaMSHortaBLBiedermanJRohdeLAThe worldwide prevalence of ADHD: a systematic review and metaregression analysisAm J Psychiatry2007164694294817541055
- PolanczykGVWillcuttEGSalumGAKielingCRohdeLAADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysisInt J Epidemiol201443243444224464188
- KooijSJBejerotSBlackwellAEuropean consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDBMC Psychiatry2010106720815868
- RöslerMCasasMKonofalEBuitelaarJAttention deficit hyperactivity disorder in adultsWorld J Biol Psychiatry201011568469820521876
- AshersonPClinical assessment and treatment of attention deficit hyperactivity disorder in adultsExpert Rev Neurother20055452553916026236
- FayyadJDe GraafRKesslerRCross-national prevalence and correlates of adult attention-deficit hyperactivity disorderBr J Psychiatry200719040240917470954
- SimonVCzoborPBálintSMészárosABitterIPrevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysisBr J Psychiatry2009194320421119252145
- National Institute for Health and Clinical ExcellenceAttention Deficit Hyperactivity Disorder: Pharmacological and Psychological Interventions in Children, Young People and Adults (Clinical Guideline 72)London, UKThe British Psychological Society and the Royal College of Psychiatrists2008
- EspositoMGallaiBParisiLVisuomotor competencies and primary monosymptomatic nocturnal enuresis in prepubertal aged childrenNeuropsychiatr Dis Treat2013992192623847418
- EspositoMCarotenutoMIntellectual disabilities and power spectra analysis during sleep: a new perspective on borderline intellectual functioningJ Intellect Disabil Res201458542142923517422
- EspositoMCarotenutoMBorderline intellectual functioning and sleep: the role of cyclic alternating patternNeurosci Lett20104852899320813159
- EspositoMAntinolfiLGallaiBExecutive dysfunction in children affected by obstructive sleep apnea syndrome: an observational studyNeuropsychiatr Dis Treat201391087109423976855
- Shire Pharmaceuticals Limited [webpage on the Internet]Equasym XL 10 mg, 20 mg or 30 mg capsulesSurrey, UKDatapharm Communications Limited2013 Available from: http://www.medicines.org.uk/emc/medicine/15804/SPC/Equasym+XL+10+mg%2c+20+mg+or+30+mg+Capsules/#CLINICAL_PARTSAccessed December 15, 2013
- Janssen-Cilag Ltd [webpage on the Internet]Concerta XL 18 mg–36 mg prolonged release tabletsSurrey, UKDatapharm Communications Limited2013 Available from: http://www.medicines.org.uk/emc/medicine/8382/SPC/Concerta+XL+18+mg+-+36+mg+prolonged+release+tablets/Accessed December 12, 2013
- Auden Mckenzie (Pharma Division) LimitedDexamfetamine Summary of Product Characteristics Updated March 23, 2010. http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1397196845267.pdfAccessed September 1, 2014
- Shire Pharmaceuticals Limited [webpage on the Internet]Elvanse 30 mg, 50 mg and 70 mg capsules, hardSurrey, UKDatapharm Communications Limited2013 Available from: http://www.medicines.org.uk/emc/medicine/27442/SPC/Elvanse+30mg%2c+50mg+%26+70mg+Capsules%2c+hard/#PHARMACOLOGICAL_PROPSAccessed October 19, 2013
- Eli Lilly and Company LimitedStrattera. Summary of Product Characteristics. [Updated December 19, 2013]. http://www.medicines.org.uk/emc/medicine/14482#INDICATIONSAccessed August 28, 2014
- FredriksenMHalmøyAFaraoneSVHaavikJLong-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studiesEur Neuropsychopharmacol201323650852722917983
- FaraoneSVBiedermanJMickEThe age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studiesPsychol Med200636215916516420712
- VrijensBDe GeestSHughesDAABC Project Team. A new taxonomy for describing and defining adherence to medicationsBr J Clin Pharmacol201273569170522486599
- HorneRWeinmanJBarberNConcordance, Adherence and Compliance in Medicine Taking: Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R&D (NCCSDO)London, UKNational Co-ordinating Centre for NHS Service Delivery and Organisation (NCCSDO)2005
- SabatéEAdherence to Long-Term Therapies: Policy for ActionGeneva, SwitzerlandWorld Health Organization2001 Available from: http://www.who.int/chp/knowledge/publications/adherencerep.pdfAccessed April 22, 2014
- BellJSAiraksinenMSLylesAChenTFAslaniPConcordance is not synonymous with compliance or adherenceBr J Clin Pharmacol2007645710711 author reply 711–71317875196
- AronsonJKCompliance, concordance, adherenceBr J Clin Pharmacol200763438338417378797
- KravitzRLMelnikowJMedical adherence research: time for a change in direction?Med Care200442319719915076818
- HorneRWeinmanJPatients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illnessJ Psychosom Res199947655556710661603
- AdlerLDNierenbergAAReview of medication adherence in children and adults with ADHDPostgrad Med2010122118419120107302
- GauSSChenSJChouWJNational survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in TaiwanJ Clin Psychiatry200869113114018312048
- DarredeauCBarrettSPJardinBPihlROPatterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate usersHum Psychopharmacol200722852953617910020
- KooijJJRöslerMPhilipsenAPredictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trialBMC Psychiatry2013133623347693
- CharachAYeungEVolpeTGoodaleTDosreisSExploring stimulant treatment in ADHD: narratives of young adolescents and their parentsBMC Psychiatry20141411024725829
- BussingRKoro-LjungbergMNoguchiKMasonDMayersonGGarvanCWWillingness to use ADHD treatments: a mixed methods study of perceptions by adolescents, parents, health professionals and teachersSoc Sci Med20127419210022133584
- Walker-NoackLCorkumPElikNFearonIYouth perceptions of attention-deficit/hyperactivity disorder and barriers to treatmentCanadian Journal of School Psychology2013282193218
- KnippDKTeens’ perceptions about attention deficit/hyperactivity disorder and medicationsJ Sch Nurs200622212012516563036
- TravellCVisserJ‘ADHD does bad stuff to you’: young people’s and parents’ experiences and perceptions of attention deficit hyperactivity disorder (ADHD)Emotional and Behavioural Difficulties2006113205216
- WongICAshersonPBilbowACessation of attention deficit hyperactivity disorder drugs in the young (CADDY) – a pharmacoepidemiological and qualitative studyHealth Technol Assess20091350iiiivixxi112019883527
- BrinkmanWBShermanSNZmitrovichARIn their own words: adolescent views on ADHD and their evolving role managing medicationAcad Pediatr2012121536122133501
- Davis-BermanJPestelloFGMedicating for ADD/ADHD: personal and social issuesInt J Ment Health Addict20108482492
- PillowDRNaylorLJMaloneGPBeliefs regarding stimulant medication effects among college students with a history of past or current usageJ Atten Disord201418324725723048049
- MeauxJBHesterCSmithBShoptawAStimulant medications: a trade-off? The lived experience of adolescents with ADHDJ Spec Pediatr Nurs200611421422616999743
- O’CallaghanPAdherence to stimulants in adult ADHDAtten Defic Hyperact Disord20146211112024604104
- MathesonLAshersonPWongICAdult ADHD patient experiences of impairment, service provision and clinical management in England: a qualitative studyBMC Health Serv Res20131318423692803
- FerrinMRuiz-VeguillaMBlanc-BetesMEvaluation of attitudes towards treatment in adolescents with attention deficit hyperactivity disorder (ADHD)Eur Child Adolesc Psychiatry201221738740122714140
- CoxDJDavisMTCoxBSBurketRCMerkelRLMikamiAYQuantifying the relationship between perceived consequences of ADHD medication and its usageJ Atten Disord Epub2012821
- RoySCCorlissCPThe Roy Adaptation Model: theoretical update and knowledge for practiceNLN Publ199315–25482152298371956
- MunroSLewinSSwartTVolminkJA review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS?BMC Public Health2007710417561997
- CharachAVolpeTBoydellKMGearingREA theoretical approach to medication adherence for children and youth with psychiatric disordersHarv Rev Psychiatry200816212613518415884
- SafrenSADuranPYovelIPerlmanCASprichSMedication adherence in psychopharmacologically treated adults with ADHDJ Atten Disord200710325726017242421
- FerrinMTaylorEChild and caregiver issues in the treatment of attention deficit-hyperactivity disorder: education, adherence and treatment choiceFuture Neurol201163399413
- HarpurRAThompsonMDaleyDAbikoffHSonuga-BarkeEJThe attention-deficit/hyperactivity disorder medication-related attitudes of patients and their parentsJ Child Adolesc Psychopharmacol200818546147318928411
- CaisleyHMüllerUAdherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: a systematic reviewEur Psychiatry201227534334922521805
- BussingRMehtaASStigmatization and self-perception of youth with attention deficit/hyperactivity disorderPatient Intell2013201351527
- CharachAGajariaAImproving psychostimulant adherence in children with ADHDExpert Rev Neurother20088101563157118928348
- ChackoANewcornJHFeirsenNUdermanJZImproving medication adherence in chronic pediatric health conditions: a focus on ADHD in youthCurr Pharm Des201016222416242320513228
- SwansonJCompliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvementCNS Drugs200317211713112521359
- YoungSMurphyCMCoghillDAvoiding the ‘twilight zone’: recommendations for the transition of services from adolescence to adulthood for young people with ADHDBMC Psychiatry20111117422051192